The aim of this study is to synthesize new benzenesulfonamide derivatives that possess antibacterial activity using Bumetanide as a precursor of benzenesulfonamide. A novel series of hydrazones containing benzenesulfonamides (4 a-i ) and 1,3,4 oxadiazole containing benzenesulfonamides (5 a-e ) were prepared and their antibacterial and antifungal activities were measured using microplate broth assay against Gram-positive: Staphylococcus aureus, Gram-negative: Escherichia coli and Pseudomonas aeruginosa and Fungi: Aspergillus fumigates and Candida albicans. The results showed that some of the prepared compounds exhibit a good to excellent activity against the mentioned bacteria, however all the series showed no activity against fungi. Among the series, Compound (4 i ) demoed an excellent antibacterial activity better than that of the standard reference (Sulfamethoxazole) against Escherichia coli, while compounds (4 c , 4 e , 4 g ) showed good activity against all tested bacterial strains equals to Sulfamethoxazole activity. Moreover, compounds (4 g , 5 d ) exert an antimicrobial activity equals to that of Sulfamethoxazole against Pseudomonas aeruginosa, while compounds (4 a , 4 b , 4 c , 4 f , 4 g , 4 h ) exhibit similar activity to Sulfamethoxazole against Escherichia coli.
Introduction
The antimicrobial resistance has turned into a menace that confronts the community over the last few decades. The use and misuse of antimicrobial agents incited the bacteria to develop resistance against them through different defensive mechanisms like enzymatic degradation, modulation of the drug targets or modifying bacterial cell membrane permeability ORIGINAL ARTICLE (Sefton; 2002) . Thus a great number of infectious diseases have become uncontrollable which contributes to high levels of morbidity and mortality (El-Sayed et al.; . According to the Centers for Disease Control and Prevention (CDC), the resistant bacteria could infect up to two million patients in the United States every year, while around 23000 person of them meet their fate due to the treatment failure (Srinivasan et al., 2012) . On the other hand, the World Health Organization (WHO) stated that though the antimicrobial agents lose their activity, there are insufficient researches that stand up to this catastrophe which means that our competence to overcome the antimicrobial resistance declines dramatically (Gorton et al., 2017) .
The researches in the field of medicinal chemistry evolved a limited number of substantial moieties, frequently present in several drug molecules and interestingly, sulfonamide moiety (SO 2 NH 2 ) is one of them (Scozzafava et al., 2012) . Sulfonamides are a pharmacologically active class of drugs that exert different pharmacological activities like antibacterial (Kamal et al. 2013; Zhang et al., 2017) , antifungal (Saha et al., 2000; Zaidi et al., 2007) , anticarbonic anhydrase (Saluja et al., 2014; Supuran et al., 2018) , diuretics (Fravolini et al., 1991; Al-Kahtani et al., 2016) , antiinflammatory (Rodge et al., 2012; Brusco et al., 2015) and anticancer (Ahmed et al., 2015; Alafeefy et al., 2016) . Among this class of drugs are sulfa drugs that are the first successfully synthesized antimicrobial agents that exert their action via competitive inhibition of folic acid synthesis, and consequently turn off the microbial nucleic acid replication. So far, a group of clinically tried sulfa drugs comprised of benzenesulfonamides bearing antibacterial active aromatic heterocycles are now widely used (Scozzafava et al., 2012) . For instance, Sulfamethoxazole, Sulfathiazole, Sulfadiazine and Sulfachloropyridazine are composed of benzenesulfonamide conjugated with isoxazole, thiazole, pyrimidine and pyridazine moieties respectively. Thus, new researches were conducted to discover novel benzenesulfonamide derivatives of antimicrobial action to overcome the antimicrobial resistance problem. For example, addition of coumarin ring to benzenesulfonamide contributed to the antimicrobial activity of compounds (1, 2) as displayed in figure (1) (Patecl et al., 2010) . Moreover, incorporation a chloro substituted imidazole derivative into benzensulfonamide moiety has enhanced antimicrobial and antitubercular activity of compounds (3, 4) shown in figure (1). (Pakkath et al., 2014) . Recently, Ghorab et al. (Soliman et al., 2019) could prepare new antimicrobial agents compounds (5,6) through conjugating thioureidobenzensulfonamide moiety with substituted pyrimidine as shown in figure (1) .
On a parallel approach, in the present investigation, we aimed at introducing new antimicrobial agents to face the antimicrobial resistance challenge. Our research is based on incorporation of well reputed antimicrobial moieties like hydrazones (Mazi et al., 2003) and 1,3,4-oxadiazoles (Othman et al., 2014) into Bumetanide as a precursor of benzenesulfonamide.
Results and discussion

Chemistry
The starting material of this investigation is Bumetanide;
3-(butylamino)-4-phenoxy-5-sulfamoylbenzoic acid (1) which was esterified with methanol in presence of sulfuric acid to afford methyl 3-(butylamino)-4-phenoxy-5-sulfamoylbenzoate (2).The ester form (2) underwent hydrazinolysis with hydrazine hydrate in ethanol to yield 3-(butylamino)-5-(hydrazinocarbonyl)-2-phenoxybenzenesulfonamide (3) as shown in scheme (1).
The acid hydrazide derivative (3) was condensed with series of different aldehydes to afford N'-arylidene-3-(butylamino)-2-phenoxybenzenesulfonamide-5-carbonylhydrazides (4 a-i ) as shown in scheme (2). On the other hand, compound (3) was condensed with different aromatic acids in presence of phosphorous oxychloride (POCl 3 ) to produce a novel series of oxadiazoles of substituted-3-(butylamino)-2-phenoxy-5-(5-aryl-1,3,4-oxadiazol-2-yl)-benzenesulfonamide (5 a-e ) as shown in scheme (3).
The structures of the novel compounds were confirmed from their spectral and micro analytical data. Structure of compound (2 6 CFU/ml using MHB for bacteria and Sabourand dextrose Broth (SDB) for tested fungi. The adjusted microbial inoculums (100 µl) were added to each well of sterile 96-well flat-bottomed micro titer plate containing the tested concentration of tested samples (100 µl/well). As a result,last inoculum concentration of 5 X 10 5 CFU/ml was obtained in each well. Three wells containing microbial suspension with no sample using DMSO employed for dissolving the tested compound (Growth control) and two wells containing only media (background control) were included in this plate. Optical densities were measured after 24 hours at 37 ○ C for bacteria and after 48 hours at 28 ○ C for fungi using a multi-detection microplate reader at The Regional Center for Mycology and biotechnology (sun Rise -Tecan, USA) at 600 nm. Sulfamethoxzole and Amphotericin B were used as standards for Gram positive bacteria, Gram negative bacteria and fungi respectively. The inhibitory percentage of the tested compounds were illustrated in the Table (1) (Ankem et al., 2009 ).
Determination of minimum inhibitory concentration (MIC) and inhibitory concentration 50 (IC50):
The antibacterial activities of the tested compounds were studied adopting the broth micro dilution method (Valgas et al., 2007) The microbial suspensions equivalent to the turbidity of 0.5 McFarland (108 CFU/ml) standard were prepared from a fresh subculture of tested bacteria in Mueller Hinton Broth (MHB) and tested fungi in Sabouraud Dextrose Broth (SDB) then this suspension was diluted to 106 CFU/ml using MHB for bacteria and Sabourand dextrose Broth (SDB) for tested fungi. The adjusted microbial inoculums (100 µl) were added to each well of sterile 96-well flat-bottomed micro titer plate containing the tested concentration of tested samples (100µl/well). As a result, last inoculum concentration of 5 X 105 CFU/ml was obtained in each well. Three wells containing microbial suspension with no sample using DMSO (Sigma-Aldrich, Germany) employed for dissolving the tested compound (Growth control) and two wells containing only media (background control) were included in this plate.
Optical densities were measured after 24 hours at 37 ○C for bacteria and after 48 hours at 28 ○ C for fungi using a multi-detection microplate reader at 600 nm. Sulfamethoxazole and Amphotericin B were used as standards for Gram positive bacteria, Gram negative bacteria and Fungi respectively. The inhibitory percentage of the tested compounds was illustrated in the Table (2). IC50 for each compound were measured during measuring the MIC, The values of IC50 IC50 for each compound were measured during measuring the MIC, The values of IC50 were illustrated in Table ( 3). 
Experimental
General techniques
All starting materials in this investigation from (Sigma-Aldrich, Germany).Melting points (°C) were determined with a Gallenkamp melting point apparatus (London, UK), and are uncorrected. Elemental analysis was performed in the Regional center for Mycology and Biotechnology, Faculty of Science, Al Azhar University, Nasr city, Cairo, Egypt.
1 HNMR and 13 CNMR were performed in NMR department, Faculty of Science, Al Mansora University.
1 HNMR spectra were recorded on Jeol resonance DELTA2-NMR (500 MHz) (Japan) using dimethyl sulfoxide (DMSO)-d 6 as a solvent and tetramethylsilane (TMS) as internal standard (chemical shift in δ, ppm). 13 CNMR spectra were recorded on Jeol resonance DELTA2-NMR (100 MHz) (Japan). All reactions were monitored by thin-layer chromatography (TLC) using Silica gel 60 GF245 (E-Merck-Germany) and were visualized by iodine vapors or by UV-lamp at wavelength λ 254 nm. (Ar-C), 114.9 (Ar-C), 115.6 (2 Ar-C), 122.3 (Ar-C), 126.9 (Ar-C), 129.1 (Ar-C), 137.9 (2 Ar-C), 139.9 (Ar-C), 142.6 (Ar-C), 156.3 (Ar-C), 165.6 (C=O) ppm.Anal. Calcd. for C 18 H 22 N 2 O 5 S: C, 57. 13; H, 5.86; N, 7.40, Found: C, 57.38; H, 5.81 ; N, 7.6%.
Elemental and experimental analysis
Methyl 3-(butylamino)-4-phenoxy-5-sulfamoylbenzoate (2). To a solution of
3-(Butylamino)-5-(hydrazinocarbonyl)-2-phenoxybenzenesulfonamide (3).
To a solution of compound (2) (1 g, 2.6 mmol) in ethanol (20 mL), hydrazine hydrate (3 mL, 61.2 mmol) was added then the mixture was refluxed for 6 hours. After cooling, the formed precipitate was filtered, washed with ethanol, dried then recrystallized from ethanol. (90%) 
General procedures for synthesis of N'-Arylidene-3-(butylamino)-2-phenoxybenzenesulfonamide -5-carbonylhydrazide (4 a-i )
To a solution of compound (3) (0.5 g, 1.07 mmol) in ethanol (20 mL), the appropriate aldehyde (0.114 mmol) was added. The reaction mixture was refluxed for 3 hours. The separated solid was filtered, washed with diethyl ether, and crystallized from ethanol. H, 5.30; N, 12.27, Found: C, 57.84; H, 4.92 ; N, 11.96%. , 5.39; N, 14.98, Found: C, 59.11; H, 5.42 ; N, 14.90%. 2H, 5.02 (t, 1H, J = 6 Hz, NH), 6.85 (d, 2H, J = 7.5 Hz, 7.00 (t, 1H, J = 7.5 Hz, 7.15 (t, 1H, J = 6.5 Hz, thiophene), 7.27 (t, 2H, J = 7.5 Hz, 7.39 (s, 1H, 7.48 (d, 1H, J = 7 Hz, thiophene) , 55.92; H, 5.12; N, 11.86, Found: C, 55.81; H, 5.36 , 5.63; N, 9.78, Found: C, 65.37; H, 5.69 To a solution of compound (3) (10 mmol), phosphorus oxychloride and an equivalent amount of aromatic acid (10 mmol) were added and the mixture was refluxed for 24 hours. Excess phosphorus oxychloride was distilled off under reduced pressure and the residue was quenched in ice. Sodium carbonate was added till neutralization takes place and the separated solid was filtered and crystallized from methylene chloride and petroleum ether.
3.2.3.33-(Butylamino)-2-phenoxy-5-[2-(pyridin-4-ylmethylene)-hydrazinecarbonyl]-benzenesulfonamide (4 c
)
3-(Butylamino)-2-phenoxy-5-[2-(thiophen-2-yl-methylene)-
Conclusion.
We have synthesized a series of benzenesulfonamides bearing hydrazones and benzenesulfonamides bearing oxadiazoles. The investigation of antibacterial screening data reveals that the synthesized compounds showed promising antibacterial activity to both Gram-positive and Gram-negative species.
Compound (4 i )exerts higher antibacterial activity than sulfamethoxazole against Escherichia coli. Many compounds showed equivalent antibacterial activity to Sulfamethoxazole either against Escherichia coli as compounds (4 a , 4 b , 4 c , 4 f , 4 g , 4 h ) or against Pseudomonas aeruginosa like compounds (4 g , 5 d ). Moreover, there was no any antifungal activity for all tested samples. Hence, the newly synthesized compounds could be considered for further improvement as lead compounds in the future to develop more potent antibacterial agents.
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